acetylcysteine has been researched along with sybr green i in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdouh, M; Couture, R; Hasséssian, HM; Talbot, S | 1 |
| Deponte, M; Krafczyk, J; Staudacher, V; Wezena, CA | 1 |
2 other study(ies) available for acetylcysteine and sybr green i
| Article | Year |
|---|---|
Retinal plasma extravasation in streptozotocin-diabetic rats mediated by kinin B(1) and B(2) receptors.
Topics: Acetylcysteine; Animals; Antioxidants; Benzothiazoles; Blood-Retinal Barrier; Bradykinin; Diabetes Mellitus, Experimental; Diamines; Dose-Response Relationship, Drug; Edema; Evans Blue; Male; Organic Chemicals; Oxidative Stress; Plasma; Quinolines; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Retina; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2008 |
Growth inhibitory effects of standard pro- and antioxidants on the human malaria parasite Plasmodium falciparum.
Topics: Acetylcysteine; Antioxidants; Ascorbic Acid; Benzothiazoles; Diamide; Diamines; Dithiothreitol; Dose-Response Relationship, Drug; Erythrocytes; Fluorescent Dyes; Host-Parasite Interactions; Humans; Hydrogen Peroxide; Inhibitory Concentration 50; Malaria, Falciparum; Organic Chemicals; Oxidants; Oxidation-Reduction; Oxidative Stress; Parasitemia; Plasmodium falciparum; Quinolines; tert-Butylhydroperoxide; Time Factors | 2017 |